Frontiers in Medical Technology (Oct 2022)

Sourcing cells for in vitro models of human vascular barriers of inflammation

  • Molly C. McCloskey,
  • Victor Z. Zhang,
  • Victor Z. Zhang,
  • S. Danial Ahmad,
  • Samuel Walker,
  • Samantha S. Romanick,
  • Hani A. Awad,
  • Hani A. Awad,
  • Hani A. Awad,
  • James L. McGrath

DOI
https://doi.org/10.3389/fmedt.2022.979768
Journal volume & issue
Vol. 4

Abstract

Read online

The vascular system plays a critical role in the progression and resolution of inflammation. The contributions of the vascular endothelium to these processes, however, vary with tissue and disease state. Recently, tissue chip models have emerged as promising tools to understand human disease and for the development of personalized medicine approaches. Inclusion of a vascular component within these platforms is critical for properly evaluating most diseases, but many models to date use “generic” endothelial cells, which can preclude the identification of biomedically meaningful pathways and mechanisms. As the knowledge of vascular heterogeneity and immune cell trafficking throughout the body advances, tissue chip models should also advance to incorporate tissue-specific cells where possible. Here, we discuss the known heterogeneity of leukocyte trafficking in vascular beds of some commonly modeled tissues. We comment on the availability of different tissue-specific cell sources for endothelial cells and pericytes, with a focus on stem cell sources for the full realization of personalized medicine. We discuss sources available for the immune cells needed to model inflammatory processes and the findings of tissue chip models that have used the cells to studying transmigration.

Keywords